Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AptarGroup, Inc. Common Stock (NY: ATR )

158.15 -0.70 (-0.44%)
Official Closing Price Updated: 7:00 PM EST, Dec 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 145,043
Open 157.82
Bid (Size) 157.64 (1)
Ask (Size) 158.66 (1)
Prev. Close 158.85
Today's Range 157.61 - 159.58
52wk Range 122.29 - 178.03
Shares Outstanding 65,959,499
Dividend Yield 1.14%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
How Is The Market Feeling About AptarGroup?
Via Benzinga
$1000 Invested In AptarGroup 20 Years Ago Would Be Worth This Much Today
Via Benzinga

Performance

YTD
+28.70%
+28.70%
1 Month
-7.91%
-7.91%
3 Month
-1.09%
-1.09%
6 Month
+12.31%
+12.31%
1 Year
+26.32%
+26.32%

More News

Read More
Aptar Named Among Top 50 of the ‘World’s Top Companies for Women 2024’ by Forbes
From AptarGroup, Inc.
Via Business Wire
Aptar Reports Third Quarter 2024 Results
From AptarGroup, Inc.
Via Business Wire
How Is The Market Feeling About AptarGroup?
Via Benzinga
Looking Into AptarGroup's Recent Short Interest
Via Benzinga
How Is The Market Feeling About AptarGroup?
Via Benzinga
Aptar Awarded Federal Government Contract to Advance Novel Sterilization Technology for Medical Devices
From AptarGroup, Inc.
Via Business Wire
This Elastic Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Via Benzinga
Aptar Announces New $500 Million Share Repurchase Authorization and Declares Quarterly Dividend
From AptarGroup, Inc.
Via Business Wire
Aptar’s N-Sorb Nitrosamine Mitigation Solution Accepted to US FDA’s Emerging Technology Program
From AptarGroup, Inc.
Via Business Wire
Green Day Has The Right Idea As September Seasonality Comes In Hot
Via Talk Markets
Topics ETFs
Aptar’s Nasal Unidose System to Deliver neffy® (epinephrine nasal spray), the First and Only FDA-Approved Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis
From AptarGroup, Inc.
Via Business Wire
ATR Stock Earnings: AptarGroup Beats EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Daniel Ackerman Named Aptar’s Chief Accounting Officer
From AptarGroup, Inc.
Via Business Wire
Aptar CFO, Robert (Bob) Kuhn, Has Decided to Step Down After 37 Years with the Company
From AptarGroup, Inc.
Via Business Wire
Aptar Reports Second Quarter 2024 Results
From AptarGroup, Inc.
Via Business Wire
Aptar Increases Quarterly Dividend by Nearly 10% Due to Continued Strong Performance
From AptarGroup, Inc.
Via Business Wire
Aptar Named One of the World’s Most Sustainable Companies 2024 by TIME
From AptarGroup, Inc.
Via Business Wire
Aptar Named One of America’s Climate Leaders by USA Today
From AptarGroup, Inc.
Via Business Wire
Aptar Releases 2023 Corporate Sustainability / ESG Report
From AptarGroup, Inc.
Via Business Wire
Aptar Receives Platinum Rating from EcoVadis for the Fourth Consecutive Year
From AptarGroup, Inc.
Via Business Wire
ATR Stock Earnings: AptarGroup Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Aptar Reports First Quarter 2024 Results
From AptarGroup, Inc.
Via Business Wire
Aptar Declares Quarterly Dividend
From AptarGroup, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.